Ithri Benamara is CEO Associate at phagos, a biotech startup developing AI-powered phage therapy. He previously worked as a VC at EQT Ventures, one of Europe's leading investment firms, where he focused on identifying and backing transformative technology companies. Prior to EQT, Ithri also contributed to scaling carbon removal technologies with ClimeFi. He holds Master's degrees in Climate Change & Sustainable Finance from Ecole des Mines de Paris and EDHEC Business School.
El espectro de una era postantibiótica, en la que las infecciones comunes podrían volver a ser mortales, está emergiendo lentamente.
The spectre of a post-antibiotic era, where common infections could once again prove lethal, is rearing its head.
